BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng X, Mai R, Zhang C, Yu D, Ren Y, Li G, Cheng B, Li L, Yu Z, Chen J. Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment. Eur J Med Chem 2021;213:113050. [PMID: 33280896 DOI: 10.1016/j.ejmech.2020.113050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Wang S, Ma P, Jiang Y, Cheng K, Yu Y, Jiang N, Miao H, Tang Q, Liu F, Zha Y, Li N. Drug conjugate-based anticancer therapy - Current status and perspectives. Cancer Letters 2023;552:215969. [DOI: 10.1016/j.canlet.2022.215969] [Reference Citation Analysis]
2 Wu M, Huang W, Yang N, Liu Y. Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy. Exp Hematol Oncol 2022;11:93. [DOI: 10.1186/s40164-022-00347-1] [Reference Citation Analysis]
3 Ni Y, Zhao W, Cheng W, Deng C, Ying Z, Li L, Wang X, Sun C, Tu J, Jiang L. Lipopeptide liposomes-loaded hydrogel for multistage transdermal chemotherapy of melanoma. J Control Release 2022;351:245-54. [PMID: 36108811 DOI: 10.1016/j.jconrel.2022.09.014] [Reference Citation Analysis]
4 Fatima M, Abourehab MAS, Aggarwal G, Jain GK, Sahebkar A, Kesharwani P. Advancement of cell-penetrating peptides in combating triple-negative breast cancer. Drug Discov Today 2022;27:103353. [PMID: 36099963 DOI: 10.1016/j.drudis.2022.103353] [Reference Citation Analysis]
5 Freitas ED, Bataglioli RA, Oshodi J, Beppu MM. Antimicrobial peptides and their potential application in antiviral coating agents. Colloids Surf B Biointerfaces 2022;217:112693. [PMID: 35853393 DOI: 10.1016/j.colsurfb.2022.112693] [Reference Citation Analysis]
6 Chen X, Liu F, Yu X, Li L, Yan J, Chen X, Liu Q, Liu B. An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114617] [Reference Citation Analysis]
7 Liang J, Guo R, Xuan M, Sun Q, Wu W. An Acid-Sensitive Nanofiber Conjugate Based on a Short Aromatic Peptide for Targeted Delivery of Doxorubicin in Liver Cancer. IJN 2022;Volume 17:2961-73. [DOI: 10.2147/ijn.s359642] [Reference Citation Analysis]
8 Zheng S, Cai Y, Hong Y, Gong Y, Gao L, Li Q, Li L, Sun X. Legumain/pH dual-responsive lytic peptide-paclitaxel conjugate for synergistic cancer therapy. Drug Deliv 2022;29:1764-75. [PMID: 35638851 DOI: 10.1080/10717544.2022.2081380] [Reference Citation Analysis]
9 Lei L, Wang X, Tang S. Novel taxanes in development: hopes or hypes? Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103727] [Reference Citation Analysis]
10 Mai R, Deng B, Zhao H, Li L, Fang Y, Li S, Deng X, Chen J. Design, Synthesis, and Bioevaluation of Novel Enzyme-Triggerable Cell Penetrating Peptide-Based Dendrimers for Targeted Delivery of Camptothecin and Cancer Therapy. J Med Chem 2022. [PMID: 35380045 DOI: 10.1021/acs.jmedchem.2c00287] [Reference Citation Analysis]
11 Wang T, Tian L, Cheng Q, Feng S, Zhang H, Zheng Z, Liu Y, Cheng M, Meng Z, Meng Q. Pep5-based antitumor peptides containing multifunctional fragments with enhanced activity and synergistic effect. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Xu L, Xu S, Xiang T, Liu H, Chen L, Jiang B, Yao J, Zhu H, Hu R, Chen Z. Multifunctional building elements for the construction of peptide drug conjugates. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang L, Chen H, Wang F, Zhang X. The development of peptide-drug conjugates (PDCs) strategies for paclitaxel. Expert Opin Drug Deliv 2022. [PMID: 35130795 DOI: 10.1080/17425247.2022.2039621] [Reference Citation Analysis]
14 Zorko M, Jones S, Langel Ü. Cell-penetrating peptides in protein mimicry and cancer therapeutics. Adv Drug Deliv Rev 2022;180:114044. [PMID: 34774552 DOI: 10.1016/j.addr.2021.114044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
15 Chen C, Wang J, Sun M, Li J, Wang HD. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery. Biomed Pharmacother 2021;145:112416. [PMID: 34781147 DOI: 10.1016/j.biopha.2021.112416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zhang X, Lei T, Du H. Prospect of cell penetrating peptides in stem cell tracking. Stem Cell Res Ther 2021;12:457. [PMID: 34391472 DOI: 10.1186/s13287-021-02522-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kong X, Xu J, Yang X, Zhai Y, Ji J, Zhai G. Progress in tumour-targeted drug delivery based on cell-penetrating peptides. J Drug Target 2021;:1-15. [PMID: 33944641 DOI: 10.1080/1061186X.2021.1920026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gayraud F, Klußmann M, Neundorf I. Recent Advances and Trends in Chemical CPP-Drug Conjugation Techniques. Molecules 2021;26:1591. [PMID: 33805680 DOI: 10.3390/molecules26061591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]